Skopos Labs, Inc. Embecta Corp. Transaction History
Skopos Labs, Inc.
- $813 Million
- Q3 2025
A detailed history of Skopos Labs, Inc. transactions in Embecta Corp. stock. As of the latest transaction made, Skopos Labs, Inc. holds 15,247 shares of EMBC stock, worth $221,843. This represents 0.03% of its overall portfolio holdings.
Number of Shares
15,247
Previous 18,638
18.19%
Holding current value
$221,843
Previous $262,000
17.94%
% of portfolio
0.03%
Previous 0.02%
Shares
5 transactions
Others Institutions Holding EMBC
# of Institutions
411Shares Held
56.8MCall Options Held
345KPut Options Held
68.7K-
Black Rock Inc. New York, NY9.19MShares$134 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.46MShares$79.5 Million0.0% of portfolio
-
American Century Companies Inc Kansas City, MO5.19MShares$75.5 Million0.04% of portfolio
-
River Road Asset Management, LLC3.25MShares$47.2 Million0.58% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY2.62MShares$38.1 Million0.69% of portfolio
About Embecta Corp.
- Ticker EMBC
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 57,836,500
- Market Cap $842M
- Description
- Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...